NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001764

Registered date:11/03/2009

Appropriate Timing to Take Anti-Hypertensive Medicine Treating Morning Hypertension in Patients with Cerebral Infarction

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedMorning hypertension Cerebral Infarction
Date of first enrollment2008/05/01
Target sample size270
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)once after breakfast calcium channel blocker (amlodipine 5mg) ACE inhibitor (perindopril 4mg) ARB (candesartan 8mg, olmesartan 20mg, valsartan 80mg, telmisartan 40mg) once after dinner calcium channel blocker (amlodipine 5mg) ACE inhibitor (perindopril 4mg) ARB (candesartan 8mg, olmesartan 20mg, valsartan 80mg, telmisartan 40mg) once at bed calcium channel blocker (amlodipine 5mg) ACE inhibitor (perindopril 4mg) ARB (candesartan 8mg, olmesartan 20mg, valsartan 80mg, telmisartan 40mg)

Outcome(s)

Primary OutcomeThe changes of blood pressure at home.
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum65years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1) low compliance 2) more than 75% carotid artery stenosis

Related Information

Contact

public contact
Name
Address Japan
Telephone 087-891-2153
E-mail
Affiliation Kagawa University School of Medicine Department of Cardiorenal and Cerebrovascular Medicine
scientific contact
Name Naohisa Hosomi
Address 1750-1 Ikenobe, Miki-cho, Kagawa Japan
Telephone
E-mail
Affiliation Kagawa University School of Medicine Department of Cardiorenal and Cerebrovascular Medicine